Results 1 to 10 of about 8,816 (194)
Teprotumumab for Thyroid-Associated Ophthalmopathy [PDF]
New England Journal of Medicine, 2017 BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns ...
Terry J Smith +2 more
exaly +8 more sources
Thyroid-associated Ophthalmopathy
Türk Oftalmoloji Dergisi, 2017 Thyroid-associated ophthalmopathy is the most frequent extrathyroidal involvement of Graves’ disease but it sometimes occurs in euthyroid or hypothyroid patients.
Esra Şahlı, Kaan Gündüz
doaj +3 more sources
Graves’ ophthalmopathy – thyroid eye disease
Journal of Education, Health and Sport, 2019 Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called
Dagna Siedlecka +3 more
doaj +6 more sources
Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy [PDF]
Journal of Ophthalmic & Vision Research, 2020 Purpose: To evaluate the effect of orbital steroid injections in patients with active thyroid ophthalmopathy resistant to or dependent on systemic steroids, or with complications related to systemic steroid use.
Abbas Bagheri +2 more
doaj +2 more sources
Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis [PDF]
International journal of ophthalmology, 2014 AIM:To determine the prevalence of ophthalmopathy in Hashimoto’s patients and to make a comparison in subgroups of patientsMETHODS:The study involved 110 Hashimoto’s thyroiditis patients and 50 control subjects attending to the endocrinology department ...
Elif Kilic Kan +3 more
core +4 more sources
Glycosaminoglycans in Thyroid-Associated Ophthalmopathy
Autoimmunity, 1992 Glycosaminoglycan (GAG) accumulation in the retrobulbar space of patients with thyroid-associated ophthalmopathy (TAO) has been documented in a number of immunohistochemical studies. In order to gain further insight into possible immunopathogenic mechanisms, the influence of humoral immunity on retrobulbar fibroblasts (RF) as GAG producing cells as ...
G Kahaly, C Stover
exaly +4 more sources
THYROID ASSOCIATED OPHTHALMOPATHY – A REVIEW [PDF]
Malaysian Family Physician, 2009 Thyroid associated ophthalmopathy is an autoimmune disorder affecting the orbital and periorbital tissues. Hyperthyroidism is commonly associated with thyroid associated ophthalmopathy, however in 5% to 10% of cases it is euthyroid.
CHONG MS +6 more
doaj +2 more sources
Advances in artificial intelligence in thyroid-associated ophthalmopathy
Frontiers in EndocrinologyThyroid-associated ophthalmopathy (TAO), also referred to as Graves’ ophthalmopathy, is a medical condition wherein ocular complications arise due to autoimmune thyroid illness.
Jing Rao, Guiqin Liu, Weihua Yang
exaly +3 more sources
FOCUS-MUSE DWI outperforms MUSE and FOCUS DWIs in orbital imaging quality and staging thyroid-associated ophthalmopathy [PDF]
Insights into ImagingObjectives To compare field-of-view optimized and constrained undistorted single-shot (FOCUS), multiplexed sensitivity-encoding (MUSE) and FOCUS-MUSE diffusion-weighted images (DWIs) in orbital imaging quality and staging performance for the patients ...
Lu Chen +9 more
doaj +2 more sources
Thyroid-Associated Ophthalmopathy in Iranian Patients [PDF]
Acta Medica Iranica, 2011 "nWe determined the frequency of clinical thyroid ophthalmopathy in Iranian patients. This cross-sectional study was performed at the Endocrinology Institute of Tehran University of Medical Sciences.
Mohsen Bahmani Kashkouli +6 more
doaj +4 more sources